Download PDF
Synfacts 2009(10): 1060-1060  
DOI: 10.1055/s-0029-1217858
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of BMS-317180

Contributor(s): Philip Kocienski
A. H. Davulcu*, D. D. McLeod, J. Li, K. Katipally, A. Littke, W. Doubleday, Z. Xu, C. W. McConlogue, C. J. Lai, M. Gleeson, M. Schwinden, R. L. Parsons Jr.*
Bristol-Myers Squibb Company, New Brunswick, USA
Further Information

Publication History

Publication Date:
22 September 2009 (online)

   Permissions and Reprints
Preview

Significance

Many of the health problems that beset the elderly may be due to deficiency in the human growth hormone (hGH) that results in ­neuroendocrine dysregulation. BMS-317180 is an orally active growth hormone secretagogue receptor agonist that has advanced into clinical ­development. The synthesis shown delivered BMS-317180 on a multi-kilogram scale.